Clinical Trial Update: Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH) [Phase 3]

View source ↗

Summary

A Phase 3, multi-center randomized trial is currently recruiting to evaluate the effectiveness and safety of ZP5-9676 for soil-transmitted helminthiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soil-transmitted Helminthiasis

Drugs mentioned

• ZP5-9676

Snippet

Sponsor: Zero Point Five Therapeutics | Conditions: Soil-Transmitted Helminthiasis (STH) | Phase 3 | Status: RECRUITING